Managed Healthcare Executive October 22, 2024
AI (artificial intelligence) can improve the accuracy of disease prediction by crunching volumes of existing clinical data on patients.
It is often stated that there is an unmet need for more treatments for treatment resistant depression (TRD), but AI is showing that available options can be used more effectively to improve prediction and treatment.
Several studies have been published recently that support the use of AI as a tool for eliminating much of the trial and error in the treatment of patients with major depressive disorders (MDD), including TRD.
Researchers stress, though, that more such studies are essential because AI is rapidly being integrated into treatment for MDD, and TRD and its utility needs to be validated.
An example of...
Today's Sponsors
Today's Sponsor